BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31562641)

  • 21. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.
    Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J
    Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
    Wa Q; Li L; Lin H; Peng X; Ren D; Huang Y; He P; Huang S
    Oncol Rep; 2018 Jan; 39(1):81-90. PubMed ID: 29138858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
    Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
    Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MAZ promotes prostate cancer bone metastasis through transcriptionally activating the KRas-dependent RalGEFs pathway.
    Yang Q; Lang C; Wu Z; Dai Y; He S; Guo W; Huang S; Du H; Ren D; Peng X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):391. PubMed ID: 31488180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multiplatform approach identifies miR-152-3p as a common epigenetically regulated onco-suppressor in prostate cancer targeting
    Ramalho-Carvalho J; Gonçalves CS; Graça I; Bidarra D; Pereira-Silva E; Salta S; Godinho MI; Gomez A; Esteller M; Costa BM; Henrique R; Jerónimo C
    Clin Epigenetics; 2018; 10():40. PubMed ID: 29599847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
    Zhao Y; Yan M; Yun Y; Zhang J; Zhang R; Li Y; Wu X; Liu Q; Miao W; Jiang H
    Oncol Rep; 2017 Apr; 37(4):2449-2458. PubMed ID: 28350134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
    Feng Q; He P; Wang Y
    Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2.
    Fan H; Zhang YS
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):539-546. PubMed ID: 30720161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-573 inhibits prostate cancer metastasis by regulating epithelial-mesenchymal transition.
    Wang L; Song G; Tan W; Qi M; Zhang L; Chan J; Yu J; Han J; Han B
    Oncotarget; 2015 Nov; 6(34):35978-90. PubMed ID: 26451614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased miR-218-5p Levels as a Serum Biomarker in Bone Metastasis of Prostate Cancer.
    Peng P; Chen T; Wang Q; Zhang Y; Zheng F; Huang S; Tang Y; Yang C; Ding W; Ren D; Huang Z; Guo Y
    Oncol Res Treat; 2019; 42(4):165-185. PubMed ID: 30870834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypoxia induced microRNA-301b-3p overexpression promotes proliferation, migration and invasion of prostate cancer cells by targeting LRP1B.
    Zheng H; Bai L
    Exp Mol Pathol; 2019 Dec; 111():104301. PubMed ID: 31442444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiRNA-296-3p-ICAM-1 axis promotes metastasis of prostate cancer by possible enhancing survival of natural killer cell-resistant circulating tumour cells.
    Liu X; Chen Q; Yan J; Wang Y; Zhu C; Chen C; Zhao X; Xu M; Sun Q; Deng R; Zhang H; Qu Y; Huang J; Jiang B; Yu J
    Cell Death Dis; 2013 Nov; 4(11):e928. PubMed ID: 24263102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-129-3p controls centrosome number in metastatic prostate cancer cells by repressing CP110.
    Bijnsdorp IV; Hodzic J; Lagerweij T; Westerman B; Krijgsman O; Broeke J; Verweij F; Nilsson RJ; Rozendaal L; van Beusechem VW; van Moorselaar JA; Wurdinger T; Geldof AA
    Oncotarget; 2016 Mar; 7(13):16676-87. PubMed ID: 26918338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of MicroRNA-489-3p promotes osteosarcoma metastasis by activating PAX3-MET pathway.
    Liu Q; Yang G; Qian Y
    Mol Carcinog; 2017 Apr; 56(4):1312-1321. PubMed ID: 27859625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
    Tang Y; Wu B; Huang S; Peng X; Li X; Huang X; Zhou W; Xie P; He P
    Oncol Rep; 2019 Jan; 41(1):57-66. PubMed ID: 30365141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidermal growth factor receptor signaling promotes metastatic prostate cancer through microRNA-96-mediated downregulation of the tumor suppressor ETV6.
    Tsai YC; Chen WY; Siu MK; Tsai HY; Yin JJ; Huang J; Liu YN
    Cancer Lett; 2017 Jan; 384():1-8. PubMed ID: 27746161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ectopic Expression of miR-532-3p Suppresses Bone Metastasis of Prostate Cancer Cells via Inactivating NF-κB Signaling.
    Wa Q; Zou C; Lin Z; Huang S; Peng X; Yang C; Ren D; Xu D; Guo Y; Liao Z; Wang B; Hu H; Huang S; He P
    Mol Ther Oncolytics; 2020 Jun; 17():267-277. PubMed ID: 32368615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-335 and -543 suppress bone metastasis in prostate cancer via targeting endothelial nitric oxide synthase.
    Fu Q; Liu X; Liu Y; Yang J; Lv G; Dong S
    Int J Mol Med; 2015 Nov; 36(5):1417-25. PubMed ID: 26647850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145.
    Guo W; Ren D; Chen X; Tu X; Huang S; Wang M; Song L; Zou X; Peng X
    J Cell Biochem; 2013 Jul; 114(7):1606-15. PubMed ID: 23355420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thrombospondin-2 promotes prostate cancer bone metastasis by the up-regulation of matrix metalloproteinase-2 through down-regulating miR-376c expression.
    Chen PC; Tang CH; Lin LW; Tsai CH; Chu CY; Lin TH; Huang YL
    J Hematol Oncol; 2017 Jan; 10(1):33. PubMed ID: 28122633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.